BCD Bioscience, a Precision Prebiotic Fiber Company, Raises $12M In Series A Funding to Develop Lead Products
13 April 2022
BCD Bioscience, a biotechnology company creating precision prebiotics from natural fibers, today announced that it has completed an oversubscribed Series A financing round of $12 million led by Acre Venture Partners.
Vertical Farming startup Infarm raises $200M for international expansion
16 December 2021
Europe-based vertical farming firm Infarm this week announced a $200 million Series D. The round, led by the Qatar Investment Authority (QIA), follows last year’s $170 million raise.
Building off Pfizer investment, microbiome-focused Vedanta expands new fundraise to launch 2 studies
22nd July 2021
Vedanta wrapped up a $68 million Series D raise Wednesday morning, which included the $25 million equity investment Pfizer plunked down back in January.
Cellares, Poseida partner on cell therapy manufacturing
14th July 2021
Poseida Therapeutics has joined Cellares’ Early Access Partnership Program (EAPP) to accelerate cell therapy manufacturing.
From Printing Steaks to Raising Cash for Cultivated Beef Rollout
7th July 2021
Aleph Farms Ltd., a startup that grew meat in space and printed the world’s first slaughter-free ribeye steak, has raised more than $100 million to bring its cultivated beef to the market as soon as next year.
Aleph Farms gets $105 million investment to bring lab-grown steaks to market
7th July 2021
Funding round is led by private equity firm L Catterton and DisruptAD, the VC arm of Abu Dhabi’s holding company ADQ.
Forward Health raises $225M from investors including The Weeknd
11th March 2021
Primary care startup Forward Health is looking to expand its tech-powered, personalized healthcare model across the U.S., and will use a new $225 million Series D raise to help make it happen.
Evox Therapeutics reels in $95M to propel exosome-based pipeline
18th February 2021
The U.K.-based biotech raised £69.2 million ($95.4 million) from the likes of OrbiMed and GV to advance a pipeline of exosome-based treatments into the clinic and further develop the technology that underpins them.
Synthetic Biology Partners With AI To Delete Food Allergies
27th January 2021
Ukko recently announced a $40M Series B funding round to advance its efforts in ending food allergies for good. The funding Series was led by Leaps by Bayer—the impact investment arm of Bayer.
Cellares Adds PACT Pharma to its Early Access Partnership Program
8th January 2021
Under the partnership, PACT Pharma will provide the company with insight into autologous NeoTCR manufacturing workflows to help identify product-market fit and secure early access to the technology for an undisclosed amount
EVOX THERAPEUTICS ANNOUNCES A MULTI-TARGET RNA INTERFERENCE AND ANTISENSE RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH LILLY
9th June 2020
Evox to use its proprietary exosome loading and CNS-targeting technologies to develop oligonucleotide drugs for the treatment of neurological disorders…
TEMASEK LEADS TROPIC BIOSCIENCES' US$28.5m SERIES B ROUND
4th June 2020
Biotech startup Tropic Biosciences, which develops high-performance varieties of tropical crops, on Thursday said it has raised US$28.5 million in a Series B round led by Singapore state investment firm Temasek, bringing its total equity funding raised to US$40 million…
SIEMENS HEALTHINEERS TO EXPAND COVID-19 TESTING TO INCLUDE ANTIBODY TEST
1st May 2020
The antibody test, which has a potential time to result of 14 minutes, will join the rest of the company’s diagnostic portfolio…
MUSHROOMS WORK THEIR MAGIC AS INVESTORS SUPPORT COMPASS PATHWAYS START-UP
27th April 2020
A British start-up using the active ingredient in so-called magic mushrooms to treat clinical depression has raised $80 million from investors, including Peter Thiel, the billionaire Paypal co-founder and early Facebook investor…
EVOX THERAPEUTICS AND TAKEDA SIGN MULTI-TARGET RARE DISEASE COLLABORATION
26th March 2020
Collaboration focuses on developing novel protein replacement and mRNA therapies and explores the targeted delivery of these payloads using Evox’s proprietary exosome technology Partnership…
FORWARD ANNOUNCES LAUNCH OF COVID-19 HOME TESTING KITS
21st March 2020
With the offering of its first at-home testing kit, Forward expands COVID-19 testing options to scale its ability to treat the growing population experiencing the barricades of an overwhelmed healthcare system…
MAGIC MUSHROOM MEDICINE PASSES FIRST CLINICAL SAFETY TRIAL
11th December 2019
Psilocybin, the main psychoactive ingredient in magic mushrooms, has taken a step towards becoming a licensed treatment for depression, with the completion of the psychedelic chemical’s first controlled clinical study.
WITH LESSONS FROM HOSPITALITY AND TECH, FORWARD EXPANDS PRIMARY CARE FOOTPRINT ON EAST COAST
22nd July 2019
The newest primary care office in the nation’s capital opened just across the street from an upscale downtown development featuring luxury condos, designer boutiques from the likes of Carolina Herrera and a Tesla showroom.